Does Antimalarial Drug Prevent COVID-19? New DGH Study Seeks Answers (Ruanne Barnabas, ICRC)

The benefits of hydroxychloroquine being investigated in multi-site clinical trial launching in April

Researchers are investigating whether hydroxychloroquine – a commonly used anti-malarial and autoimmune drug – can prevent COVID-19.

A multi-site clinical trial, led by the University of Washington Department of Global Health/International Clinical Research Center (ICRC)  in collaboration with NYU Grossman School of Medicine, aims to definitively determine whether hydroxychloroquine can prevent transmission in people exposed to the virus.

New seminar series: Exploring and Understanding the COVID-19 Pandemic

Join us for this exciting new lecture series featuring UW researchers, covering topics from testing and response measures to vaccine development and social & economic impacts.

When: Mondays, April 13 - May 18, 4:00–4:50 p.m

Where: Via Zoom for UW students taking the course for credit; for all others, via video link after the course. We will post the video link on this page once it's available.

US Hospitals Could Be Overwhelmed in the Second Week of April (IHME)

In a forecast based on new data analyses, researchers find demand for ventilators and beds in US hospital intensive care units (ICUs) will far exceed capacity for COVID-19 patients as early as the second week of April. Deaths related to the current wave of COVID-19 in the US are likely to persist into July, even assuming people protect themselves and their communities by strongly adhering to social distancing measures and by taking other precautions advised by public health officials. 

Major Deworming Project Receives Additional $5 Million from Gates Foundation, Moves to the UW (UW School of Public Health - Quotes Judd Walson)

DeWorm3, a multi-country project researching the control and elimination of parasitic worms, funded by the Bill and Melinda Gates Foundation, will now be hosted by the University of Washington. Judd Walson, principal investigator of the project and vice chair and professor in the Department of Global Health at the UW, which bridges the Schools of Public Health and Medicine, has received a new, nearly $5 million grant from the foundation to oversee the transition and lead the project into its next phase.

Pages